Is a new CEO equipped for their uniquely broad and demanding role? A 2018 report by Egon Zehnder suggests many are not. Four hundred and two CEOs from 11 countries were surveyed – and 273 of them admitted that, in hindsight, they weren’t fully prepared. Together, they are running companies with a total of US$2.6 trillion in sales.
As Contract Development and Manufacturing Organizations (CDMOs) in the BioPharma space have boomed and broadened their capabilities in recent years, they have entered a more complex era that presents a host of new challenges.
As the country’s unemployment rate approaches record lows at about 3.8% and Americans place an ever greater value on their job security, corporations are finding it more challenging to fill their executive vacancies with a qualified, diverse set of individuals willing to switch jobs. And yet the difficulties associated with matching competent candidates with high-level corporate positions are a chronic test spanning decades.